Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease (Q58949856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

Lorenzo Salvatore Malatino

17 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Mallamaci F

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tripepi G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Cutrupi S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Pizzini P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1253-1258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

Urotensin II in the cardiovascular system.

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Is urotensin-II the new endothelin?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Plasma concentration of urotensin II is raised in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Congestive heart failure and expression of myocardial urotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Plasma urotensin II in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Plasma urotensin in human systolic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Role of urotensin II in patients on dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Urotensin II: a new mediator in cardiopulmonary regulation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Urotensin II evokes potent vasoconstriction in humans in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Differential levels of "urotensin-II-like" activity determined by radio-receptor and radioimmuno-assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Urotensin II in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Inflammation and atherosclerosis in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000114

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16508659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference